🔗 Visit the ClinicalTrials.gov page for NCT03702582
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Dabigatran versus warfarin in patients with atrial fibrillation. | N Engl J Med | 2009 | 39.97 |
| 2 | Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. | N Engl J Med | 2011 | 28.99 |
| 3 | Apixaban versus warfarin in patients with atrial fibrillation. | N Engl J Med | 2011 | 23.50 |
| 4 | Edoxaban versus warfarin in patients with atrial fibrillation. | N Engl J Med | 2013 | 7.70 |
| 5 | Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery. | N Engl J Med | 2016 | 4.67 |
| 6 | Novel oral anticoagulants vs warfarin for the management of postoperative atrial fibrillation: clinical outcomes and cost analysis. | Am J Surg | 2015 | 0.80 |
| 7 | Rivaroxaban vs. Warfarin for Anticoagulation in Patients with Atrial Fibrillation Undergoing Ablation and Cardioversion. | Am Fam Physician | 2016 | 0.75 |